secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K/A
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001213900-26-039691
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud

OSR Holdings (OSRH) Enters Binding Term Sheet for VXM01 License with BCM Europe; $815M Milestones, $30M Facility
--------------------------------------------------------------------------------

- The binding term sheet grants BCM Europe exclusive worldwide rights to VXM01, with OSR Holdings providing up to $30M development financing to Vaximm AG.
- BCM Europe Fund will pay up to $815M in milestone payments directly to OSR Holdings upon clinical and regulatory achievements.
- OSR Holdings retains an equity option to issue up to $15M of common stock at $10/share (premium to market) to BCME Fund.
- Royalties from an ultimate licensee will pass through to OSR Holdings after recovery of a negative milestone delta and minimum preferred return.
- The transaction is a related-party deal requiring an independent fairness opinion; the term sheet supersedes a prior January 2026 term sheet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026039691/0001213900-26-039691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000121390026039691/ea0285057-8ka1_osr.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-039691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer